Psoriasis (PsO), psoriatic arthritis (PsA), and obesity are distinct conditions that are interrelated in prevalence and share complex immunopathogenic mechanisms. Evidence indicates that overlap in these conditions results in a feedback cycle that exacerbates each condition’s effects. Current guidelines and expert consensus recommend an integrated whole-person approach to managing patients with PsO and PsA and comorbid obesity. This activity explores managing obesity care in patients with psoriasis or psoriatic arthritis.

Learning Objectives

---

At the conclusion of this activity, participants should be able to:

• Evaluate the evidence for the correlation between PsO, PsA, and obesity, including obesity-associated comorbidities
• Implement recommended screening and management practices for obesity in patients with PsO and/or PsA
• Apply expert guidance to have clear, yet compassionate and culturally sensitive conversations with patients around weight and metabolic health
• Integrate patient goals and preferences into management plans for patients with PsO/PsA and obesity

Acknowledgment of Commercial Support

---

This activity is supported by an educational grant from Lilly.